CASM CAS Medical Systems

CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

BRANFORD, Conn., July 27, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results for the second quarter of 2018 on Thursday, August 2.  Management will host a conference call to discuss these results and answer questions at 10:00 a.m. Eastern time that day.

Conference call dial-in information is as follows:

  • U.S. callers: (800) 608-8202 
  • International callers: (702) 495-1913

Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: .

A telephone replay will be available from 1:00 p.m. Eastern time on August 2, 2018, through 11:59 p.m. Eastern time on August 25, 2018.  Replay dial-in information is as follows:

  • U.S. callers: (855) 859-2056
  • International callers: (404) 537-3406
  • Conference ID number (U.S. and international): 2195364
  • The replay will also be available at .

About CASMED® – Monitoring What's Vital

CASMED FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain.  Direct monitoring of tissue oxygenation can provide a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygen in the brain and empower them to improve patient care.  For further information regarding CASMED, visit the Company's website at .

Company Contacts

CAS Medical Systems, Inc.

Jeffery A. Baird

Chief Financial Officer

(203) 315-6303

Investors

LHA Investor Relations

Bruce Voss / Jody Cain

(310) 691-7100



 

@LHA_IR_PR

EN
27/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CAS Medical Systems

 PRESS RELEASE

CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and F...

CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the three and 12 months ended December 31, 2018. The Company expects net sales from continuing operations for the fourth quarter of 2018 to be approximately $5.8 mill...

 PRESS RELEASE

CASMED to Present at the 11th Annual LD Micro Main Event Conference on...

CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5 BRANFORD, Conn., Nov. 28, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 11th Annual LD Micro Main Event Conference on Wednesday, December 5, 2018, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will be available for one-on-one m...

 PRESS RELEASE

CASMED Reports Third-Quarter 2018 Financial Results

CASMED Reports Third-Quarter 2018 Financial Results FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, today reported financial results for the three and nine months ended September 30, 2018. Net sales from continuing operations for the third quarter of 2018 were $5.4 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch